Robert Pearl A whopping one in eight U.S. adults have taken GLP-1 drugs like Wegovy and Ozempic for weight loss and related conditions. Their popularity and efficacy have sparked a prescription-writing frenzy in recent years, leaving both medications on the Food and Drug Administration’s drug shortage list since May 2023. But even when the supply rebounds, access to these … [Read more...] about How Congress can quickly make Ozempic, Wegovy affordable